| Financial Year |
March 31 2023 |
| Monetary Funds |
8,467,560,332.76 |
| Held-for-trading Financial Assets |
24,322,467.37 |
| Notes Receivable |
-- |
| Accounts Receivable |
8,397,799,581.72 |
| Advances to Suppliers |
224,482,334.54 |
| Other Receivables |
351,592,487.05 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
1,272,992.16 |
| Dividend Receivable |
-- |
| Inventories |
8,307,451,872.37 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
83,752,279.60 |
| Other Current Assets |
1,048,244,533.54 |
| Total Current Assets |
27,027,487,299.05 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
275,622,802.93 |
| Investment Properties |
-- |
| Fixed Assetes |
10,923,933,841.43 |
| Under-construction Projects |
3,937,890,531.07 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
4,969,795,303.74 |
| R&D expenses |
1,304,888,042.30 |
| Goodwill |
22,187,578,526.42 |
| Long-Term Deferred and Prepaid Expenses |
405,149,809.86 |
| Deferred Income Tax Assets |
1,310,784,829.37 |
| Other Non-Current Assets |
289,855,604.25 |
| Sub-Total of Non-Current Assets |
47,087,086,651.18 |
| Total Assets |
74,114,573,950.23 |
| Short-Term Loans |
6,606,086,887.16 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,329,774,544.20 |
| Accounts Payable |
9,807,471,466.34 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
983,108,227.15 |
| Taxes Payable |
561,764,121.94 |
| Interest Payable |
18,380,259.83 |
| Dividend Payable |
64,960.00 |
| Other payables |
1,733,406,374.99 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
682,535,749.96 |
| Other Current Liabilities |
247,802,424.26 |
| Sub-Total of Current Liabilities |
23,019,388,447.35 |
| Long-term Loans |
3,070,977,429.16 |
| Bonds Payable |
7,651,641,106.23 |
| Long-Term Accounts Payable |
156,397,103.88 |
| Special Payable |
-- |
| Estimatied Liabilities |
40,748,287.47 |
| Deferred Income Tax Liabilities |
1,597,716,129.09 |
| Other Non-Current Liabilities |
78,756,498.73 |
| Sub-Total of Non-Current Liabilities |
14,103,157,152.43 |
| Total Liabilities |
37,122,545,599.78 |
| Paid-In Capital(Or Share Stock) |
1,242,807,535.00 |
| Capital Surplus |
25,112,321,922.23 |
| Surplus Reserve |
333,980,329.72 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
7,743,301,751.89 |
| Minority Stockholder's Interest |
700,798,255.32 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
36,291,230,095.13 |
| Owner's Equity（Stockholder's Equity） |
36,992,028,350.45 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
74,114,573,950.23 |
